Shares of U.S. Physical Therapy, Inc. (NYSE:USPH – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the seven brokerages that are covering the stock, MarketBeat.com reports. Two analysts have rated the stock with a hold recommendation, four have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $98.25.
A number of equities analysts recently commented on USPH shares. Weiss Ratings reiterated a “hold (c-)” rating on shares of U.S. Physical Therapy in a research report on Wednesday, August 26th. Citigroup reissued a “market outperform” rating on shares of U.S. Physical Therapy in a research note on Wednesday, August 19th. JPMorgan Chase & Co. upped their target price on U.S. Physical Therapy from $90.00 to $95.00 and gave the company an “overweight” rating in a report on Friday, September 11th. Finally, Barrington Research raised their target price on U.S. Physical Therapy from $90.00 to $98.00 and gave the stock an “outperform” rating in a research note on Monday, August 10th.
U.S. Physical Therapy Trading Down 0.1%
Shares of USPH opened at $88.69 on Friday. U.S. Physical Therapy has a 52-week low of $58.19 and a 52-week high of $93.50. The company has a quick ratio of 1.27, a current ratio of 1.27 and a debt-to-equity ratio of 0.48. The firm’s fifty day moving average is $82.07 and its two-hundred day moving average is $74.50. The stock has a market cap of $1.32 billion, a PE ratio of 521.71, a price-to-earnings-growth ratio of 2.25 and a beta of 1.12.
U.S. Physical Therapy (NYSE:USPH – Get Free Report) last issued its earnings results on Thursday, August 6th. The company reported $0.75 EPS for the quarter, missing analysts’ consensus estimates of $0.81 by ($0.06). U.S. Physical Therapy had a net margin of 3.97% and a return on equity of 9.39%. The business had revenue of $214.06 million during the quarter, compared to analyst estimates of $211.36 million. During the same quarter last year, the company earned $0.81 earnings per share. U.S. Physical Therapy’s quarterly revenue was up 8.5% on a year-over-year basis. Research analysts forecast that U.S. Physical Therapy will post 2.89 earnings per share for the current fiscal year.
U.S. Physical Therapy Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, September 11th. Investors of record on Friday, August 21st were issued a $0.46 dividend. The ex-dividend date of this dividend was Friday, August 21st. This represents a $1.84 dividend on an annualized basis and a dividend yield of 2.1%. U.S. Physical Therapy’s dividend payout ratio is currently 1,082.35%.
Institutional Investors Weigh In On U.S. Physical Therapy
Hedge funds and other institutional investors have recently bought and sold shares of the company. BlackRock Inc. acquired a new position in U.S. Physical Therapy in the 2nd quarter valued at about $155,505,000. William Blair Investment Management LLC purchased a new stake in shares of U.S. Physical Therapy in the 2nd quarter valued at approximately $30,013,000. Bank of America Corp DE purchased a new stake in shares of U.S. Physical Therapy in the 2nd quarter valued at approximately $19,381,000. Bank of New York Mellon Corp acquired a new stake in shares of U.S. Physical Therapy during the 2nd quarter worth approximately $9,087,000. Finally, Copeland Capital Management LLC increased its holdings in shares of U.S. Physical Therapy by 11.8% during the 3rd quarter. Copeland Capital Management LLC now owns 940,528 shares of the company’s stock worth $80,632,000 after buying an additional 98,984 shares during the last quarter.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc (NYSE: USPH) operates outpatient physical therapy clinics throughout the United States. The company provides treatment and rehabilitation services for patients recovering from injuries, surgeries, illnesses and other conditions that affect movement, strength and physical function.
In addition to company-operated clinics, U.S. Physical Therapy develops and manages physical therapy practices in partnership with local physical therapists. Its services generally include orthopedic and sports rehabilitation, post-operative therapy, treatment for musculoskeletal conditions and other forms of outpatient rehabilitation.
See Also
- Five stocks we like better than U.S. Physical Therapy
- Amex Stock Slides on Job Cuts, But the Real Story Is Macro
- Chefs’ Warehouse Has Rallied 76%—Can the Stock Keep Climbing?
- MarketBeat Week in Review – 10/19 – 10/23
- Spotify Soars After Earnings as the Company Touts AI Benefits and Moderating Costs
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.
